CRISPR Therapeutics AG CRSP 深 滬
已收盤 09-19 16:00:00 美东时间
62.32
-0.620
-0.99%
華盛通- 最 高64.1784
- 今 開63.18
- 成交量 523.42万股
- 最 低 62.27
- 昨 收 62.94
- 總市值 56.68亿
- 52周最高 71.13
- 市盈率 靜 --
- 換手率 5.76%
- 52周最低 30.04
- 委 比 -3.46%
- 總股本 9095.04万
- 歷史最高 220.20
- 量 比 1.80
- 振 幅 3.03%
- 歷史最低 13.50
- 每 手 1
- 風險率 7.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Crispr Therapeutics AG Surges Amid Analyst Praise
Crispr Therapeutics AG ( ($CRSP) ) has risen by 7.75%. Read on to learn why. Cr...
09-20 22:02
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
小摩看好CRISPR(CRSP.US)基因编辑管线潜力 首予“增持”评级目标价70美元
小摩首次对CRISPR Therapeutics给出“增持”评级，并强调该公司凭借其管线潜力在基因编辑领域占据独特优势。
09-19 09:01
JP Morgan Initiates Coverage On CRISPR Therapeutics with Overweight Rating, Announces Price Target of $70
JP Morgan analyst Brian Cheng initiates coverage on CRISPR Therapeutics (NASDAQ:CRSP) with a Overweight rating and announces Price Target of $70.
09-18 18:55
How Is The Market Feeling About CRISPR Therapeutics?
CRISPR Therapeutics's (NYSE:CRSP) short interest as a percent of float has fall...
09-13 02:00
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
CRISPR Therapeutics will present its Phase 1 clinical data on CTX310™, a CRISPR/Cas9 gene editing therapy targeting ANGPTL3 for cardiovascular diseases, and preclinical data on CTX340™ targeting AGT for hypertension at the American Heart Association Scientific Sessions 2025 in New Orleans. The oral presentation on CTX310 will take place on November 8, 2025, at 8:30 a.m. CST, while the poster on CTX340 will be presented later the same day. Both st...
09-09 20:00
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
09-03 01:35
Crescent Biopharma to Present at September Investor Conferences
Crescent Biopharma, Inc. (Nasdaq: CBIO), a biotech company focused on advancing cancer therapies, announced management will present at two investor conferences in September: the Cantor Global Healthcare Conference 2025 on September 4, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025. Both presentations will be available for live webcast and replay on the company's website at https://investors.crescentbiop...
08-28 11:30
Peering Into CRISPR Therapeutics's Recent Short Interest
CRISPR Therapeutics's (NYSE:CRSP) short percent of float has fallen 12.58% sinc...
08-22 21:00
投资者正获利了结？ARK创新ETF(ARKK.US)遭大规模赎回 “木头姐”伍德仍在逢低买入更多股票
由“木头姐”伍德管理的ARK创新ETF今年以来表现亮眼，但近期资金流向显示投资者可能在获利了结
08-20 06:00
